Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

High immunogenicity rabies virus glycoprotein, its preparation method and application

A technology of rabies virus and high immunity, which is applied in the field of 0., the preparation of highly immunogenic rabies virus glycoprotein, and the field of highly immunogenic rabies virus glycoprotein, to reduce production costs, avoid vaccine failure, and improve immunogenicity Effect

Inactive Publication Date: 2013-03-13
MILITARY VETERINARY RES INST PLA MILITARY MEDICAL ACAD OF SCI
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Glycoproteins of different rabies virus strains differ in their immunogenicity, study shows

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High immunogenicity rabies virus glycoprotein, its preparation method and application
  • High immunogenicity rabies virus glycoprotein, its preparation method and application
  • High immunogenicity rabies virus glycoprotein, its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Artificial Synthesis of Highly Immunogenic Rabies Virus Glycoprotein Gene

[0030] The gene shown in SEQ No.1 is divided into two parts, the A fragment of 1-730bp and the B fragment of 710-1575bp, and TaKaRa (Dalian) Company is entrusted to carry out artificial synthesis respectively, and the synthesized A and B gene fragments are cloned into The BamHI site of the pUC18 plasmid vector was transformed into Escherichia coli JM109 competent, and the recombinant plasmid obtained by screening was positively connected, that is, the upstream of the fragment was close to the HindIII site and the downstream was close to the EcoRI site, and the SphI site at the 721bp position of the sequence could be used as the next One-step gene cloning. The new plasmid was named pUC18-A ( Figure 4 ) and pUC18-B ( Figure 5 ), the A and B sequence fragments in the plasmid have been sequenced and are completely consistent with the DNA sequence shown in SEQ No1.

Embodiment 2

[0032] Construction of recombinant adenovirus with highly immunogenic rabies virus glycoprotein

[0033] Plasmid pUC18-A was double-digested with restriction endonucleases HindIII and SphI, and a 730bp A fragment was recovered, and pUC18-B was double-digested with SphI and EcoRI, and an 870bp B fragment was recovered. Then, the adenoviral shuttle plasmid pacAd5 CMV was double-digested with HindIII and EcoRI, and a 6.2kb vector fragment was recovered. The carrier fragment was connected with the two gene fragments A and B under the action of T4 DNA ligase, transformed into Escherichia coli JM109 competent, and the recombinant plasmid pacAd5 CMV-optG ( Figure 6 ). Plasmids pacAd5 CMV-optG and pacAd5 9.2-100, 100 μg each, were mixed with liposomes (Invitrogen lipofectamine 2000) and then transfected into 293AD monolayer cells. The culture was continued for 5 days, and the cell culture was harvested until obvious cells became round and aggregated into bunches of grapes. The c...

Embodiment 3

[0035] Preparation of recombinant adenovirus expressing highly immunogenic rabies virus glycoprotein

[0036] The recombinant adenovirus rAD5-optG seed virus obtained in Example 2 was inoculated with 5% volume of 293AD monolayer cells, 37 ° C, 5% CO 2 Cultivate under conditions for 4-6 days, and harvest the culture by freezing and thawing when the cells become obviously round and aggregate into grape bunches. After harvesting, the virus can be expanded and inoculated according to this method, and a large amount of recombinant adenovirus rAD5-optG can be prepared.

[0037] Take the recombinant virus prepared in each batch, press 1, 10, 10 2 、10 3 、10 4 ...10 11 Perform gradient dilution, inoculate 293AD monolayer cells in a 96-well plate, inoculate 8 replicate wells for each gradient, and use 100 μl of culture medium in each well. 37°C, 5% CO after inoculation 2 Cultured under conditions for 7 days, observe and record whether there is cytopathy in each well. Recombinan...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a high immunogenicity rabies virus glycoprotein and its preparation method as well as application. The preparation method consists of: performing artificial synthesis to acquire an all dominant neutralization epitope-containing and codon optimized rabies virus glycoprotein gene, then taking a recombinant adenovirus, a recombinant baculovirus or a slow virus as an expression vector, and performing high-efficiency expression in a mammalian cell line, an insect cell line or a silkworm expression system, thus obtaining the rabies virus glycoprotein that has high immunogenicity to domestic epidemic rabies virus strains currently. And the high immunogenicity rabies virus glycoprotein is used for immunoprophylaxis of animal rabies.

Description

Technical field: [0001] The invention relates to a highly immunogenic rabies virus glycoprotein, in particular provides a preparation method and application of a highly immunogenic rabies virus glycoprotein, and belongs to the technical field of genetic engineering vaccines. Background technique: [0002] Rabies is a zoonotic disease with almost 100% fatality rate. my country is an area with a high incidence of rabies, and human rabies is mainly caused by biting or scratching (exposure) by dogs or cats carrying rabies virus. There are many rabies virus strains prevalent in my country. Although they all belong to genotype 1 and have cross protection among each other, the strains used in the current rabies vaccine are all foreign strains (PV, PM, SAD) and early Chinese epidemic strains (CTN, aG), Decades of evolution have resulted in distinct differences in glycoprotein genes. Studies have shown that the glycoproteins of different rabies virus strains have different immunog...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/145C12N15/47C12N15/861A61K39/205A61P31/14
Inventor 张守峰扈荣良刘晔王颖陈奇张菲
Owner MILITARY VETERINARY RES INST PLA MILITARY MEDICAL ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products